Oversold Stock Signal: KA
Report Date: 03-04-2024
Symbol: KA - Kineta, Inc.
Sector:
Industry:
Oversold Stock Signal: KA
Kineta, Inc. (KA)
219 Terry Ave. N
Seattle, WA 98109
Phone: 206 378 0400
Website: https://kinetabio.com
CEO: Dr. Shawn P. Iadonato Ph.D.
NASDAQ, NASDAQ Capital Market
Kineta, Inc., a clinical stage biotechnology company, develops immunotherapies for oncology, neuroscience, and biodefense. It serves private, government, and industry partners. The company has strategic partnerships with Pfizer, Genentech, Wellcome, and Samsung Biologics Co., Ltd. Kineta, Inc. was formerly known as Lecura, Inc. The company was incorporated in 2007 and is based in Seattle, Washington.